What it sells
We provide a curated, evidence- based answer to any clinical question.
Business model breakdown
Buyer: who owns the budget?
Pharmacy directors / health system leaders who hire a virtual DI pharmacist service (30+ health systems); individual clinical pharmacists can sign up free.
Trigger: what makes them buy now?
Drug information literature searching is tedious and consumes pharmacist FTEs; health systems want pharmacists to practice at top of license.
Workflow: what inputs become what output?
A pharmacist submits a clinical question; InpharmD researchers plus AI perform a custom literature search and return a customized evidence-based answer within the requested time; prior answers searchable.
Economics: what it saves and how it charges
Health-system subscription for a virtual drug information service; claims 4x+ ROI, 163,258 pharmacist hours saved, and a study showing $5.2M saved and 45 fewer deaths.
Distribution: how it reaches customers
Free sign-up for 20,000+ individual pharmacists funnels to health-system contracts; case studies (UCLA Health, OhioHealth, Riverside).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.